About Volassom™
Volassom™ is an advanced biostimulatory dermal filler developed by CGBIO, a South Korean regenerative medicine company known for its expertise in biomaterials. Based on Calcium Hydroxylapatite (CaHA), Volassom™ is designed to provide immediate volume restoration while promoting long-term collagen production. It is supplied in 2 x 0.8 ml prefilled syringes, making it ideal for volumizing procedures with precision.
Volassom™
Volassom™ is an advanced biostimulatory dermal filler developed by CGBIO, a South Korean regenerative medicine company known for its expertise in biomaterials. Based on Calcium Hydroxylapatite (CaHA), Volassom™ is designed to provide immediate volume restoration while promoting long-term collagen production. It is supplied in 2 x 0.8 ml prefilled syringes, making it ideal for volumizing procedures with precision.
Volassom™ combines high-density microspheres of CaHA suspended in a gel carrier. The gel provides immediate contouring, while the CaHA microspheres stimulate neocollagenesis over time. The result is a natural-looking lift and improvement in skin texture and elasticity. Volassom™ is especially suited for mid-face volumization, jawline definition, and cheek augmentation.
About CGBIO
CGBIO is a leader in regenerative medicine and biomaterials based in South Korea. The company is known for combining scientific rigor with clinical innovation to develop advanced injectable solutions. Their CaHA-based products, including Volassom™ and Facetem™, are a reflection of their mission to provide effective, safe, and long-lasting results in aesthetic medicine. With deep roots in tissue engineering and orthobiologics, CGBIO brings next-level expertise to facial rejuvenation.